跳至主要内容
临床试验/NCT03891056
NCT03891056Unknown不适用

METABOLIC SURGERY FOR PATIENTS WITH TYPE 2 DM AND GRADE I OBESITY (BMI 30-35 kg/m2) WITH BAD METABOLIC CONTROL (HbA1c > 7,5%) PROTOCOL

Hospital Universitario Doctor Peset2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Number of participans with normal glycosylated hemoglobin levels

研究概览

简要总结

The aim of the study is to compare the efficacy of laparoscopic gastric bypass versus vertical gastrectomy for the resolution of DM in patients with BMI 30-35.

详细描述

Hyphotesis Laparoscopic gastric bypass is the elective technique in the face of sleeve gastrectomy to improve or heal type 2 diabetes mellitus in patientes with BMI 30-35 kg/m2.

MAIN AIM:

To compare cure rate through the improvement in glycated hemoglobin and fasting glycaemia after laparoscopic gastric bypass face to sleeve gastrectomy.

SECONDARY AIMS:

To quantify both insulin and oral hypoglycemic agents dose decrease. To measure weight loss and its maintenance during the follow-up in both techniques.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

The study will be blinded for patients, who will not know the surgery technique they will go on. Dieticians and Endocrinologists who will follow the patients up after the surgery neither will not know it, so differences in dietary recommendations will not appear with this masking.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Both sex patients aged between 18 and 65 years old
  • Class I obesity (BMI 30-35 kg/m2) with bad metabolic control (DM-2 with HbA1c > 7,5%) and non-insulin anti-diabetic treatment failure (it is necessary >10 years of known diabetes evolution time, C-peptide≥ 1 ng/ml, no insulin treatment, at least two oral hypoglycemic agents treatment);
  • Patients who accomplish the follow-up protocol designed by both Surgery and Endocrinology departments
  • Informed consent signed

排除标准

  • Patients who do not accomplish the previosly described inclusion criteria; Patient's refusal to take part in the study; Patients with symptomatology of gastroesophageal reflux disease or with upper gastrointestinal series compatible with this desease.
  • Previous bariatric surgery

研究组 & 干预措施

Gastric bypass

Active Comparator

Twenty patients will be randomly assigned to perform a laparoscopic gastric bypass.

干预措施: metabolic surgery (Procedure)

Slevee gastrectomy

Active Comparator

Twenty patients will be randomly assigned to perform a sleeve gastrectomy

干预措施: metabolic surgery (Procedure)

结局指标

主要结局

Number of participans with normal glycosylated hemoglobin levels

时间窗: 1 year after surgery

Healing will be defined when HbA1c and fasting glycaemia levels are inside normal limits (Hb1Ac \< 6%, FBG\<100mg/dl) without needing oral hypoglycemic agents.

次要结局

  • Number of participants with partial remission or improvement of diabetes(1 year after surgery)
  • Comparison of weight loss between the two techniques; bypass and sleeve.(2 years after surgery)
  • Evaluation of postoperative complications in patients undergoing bypass and slevee with Clavien-Dindo classification.(1 month after surgery)
  • Comparison postoperative pain in sleeve and bypass with analogue assessment scale of postoperative pain.(3 days postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nuria Peris Tomás

Principal Investigator

Hospital Universitario Doctor Peset

研究点 (2)

Loading locations...

相似试验